Advances in Mitochondrial Dysfunction and Its Role in Cardiovascular Diseases

Area of Science:

• Mitochondrial biology
• Cardiovascular pathophysiology
• Translational medicine

Background:

• Cardiovascular diseases (CVDs) are a leading cause of death globally.
• Complex mechanisms beyond traditional risk factors drive CVD progression.
• Mitochondrial dysfunction is increasingly recognized as a central player in CVD pathogenesis.

Purpose of the Study:

• To synthesize current knowledge on mitochondrial dysfunction in CVD.
• To explore the link between mitochondrial dysregulation and CVD progression.
• To evaluate mitochondria-targeted therapeutic strategies for CVD.

Main Methods:

• Comprehensive literature review of recent research.
• Focus on mitochondrial energy metabolism, membrane potential, and dynamics (fusion/fission, mitophagy, biogenesis).
• Critical evaluation of pharmacological, gene, and regenerative therapies.

Main Results:

• Mitochondrial dysfunction contributes to endothelial dysfunction, myocardial injury, and cardiac remodeling.
• Dysregulation in energy metabolism, membrane potential, and dynamics are implicated.
• Emerging therapies target mitochondria to address CVD.

Conclusions:

• Understanding mitochondrial mechanisms in CVD is crucial for developing novel diagnostic biomarkers and precision therapeutics.
• Targeting mitochondria presents significant translational challenges and opportunities for transforming CVD management.
• Bridging mitochondrial biology and clinical cardiology is essential for future advancements.